SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/2553E007FACD718A21172126650EFB9F848E339E0B83F7E6D4B1BE4C9A4100313FB023FD69C581365FB0E0678C513EA4>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/2553E007FACD718A21172126650EFB9F848E339E0B83F7E6D4B1BE4C9A4100313FB023FD69C581365FB0E0678C513EA4
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/2553E007FACD718A21172126650EFB9F848E339E0B83F7E6D4B1BE4C9A4100313FB023FD69C581365FB0E0678C513EA4
http://www.w3.org/2000/01/rdf-schema#comment
"we not only confirmed the elevated MAC30 mRNA but also demonstrated that GC with overexpression of MAC30 resisted to adjuvant platinum-based chemotherapy."
xsd:string
http://purl.uniprot.org/uniprot/#_9F7D1768070439AA90F58352C083C701886D021AABB2A98E88486D3ABB1D5D49D12FFB1A584FE13BE728992FFA726945
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/2553E007FACD718A21172126650EFB9F848E339E0B83F7E6D4B1BE4C9A4100313FB023FD69C581365FB0E0678C513EA4
http://purl.uniprot.org/uniprot/Q5BJF2
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/2553E007FACD718A21172126650EFB9F848E339E0B83F7E6D4B1BE4C9A4100313FB023FD69C581365FB0E0678C513EA4
http://purl.uniprot.org/uniprot/#_Q5BJF2-mappedCitation-28972404
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/2553E007FACD718A21172126650EFB9F848E339E0B83F7E6D4B1BE4C9A4100313FB023FD69C581365FB0E0678C513EA4